Got a text today asking if I was interested in participating in a clinical trial for knee osteoarthritis.
It is early days - Phase 1A. The company is Cytonics and the drug CYT-108.
I've started researching a little and I'm reading some familiar themes.... 'Holy grail'....... 'may be the first and only disease-modifying pharmaceutical for OA'....... 'aim to partner with a mid-sized pharmaceutical company' ...... sound familiar?
They make interesting claims like:
In our preclinical studies, CYT-108 showcased promising results that emphasize its potential efficacy and safety. CYT-108 demonstrated up to 60% reduction in cartilage degradation and joint membrane inflammation compared to controls, and it was well-tolerated by the study subjects.
It's intraarticular. Haven't learnt much more yet.
If anyone knows much more about it, would love to hear.
There are a number of links but this one I found particularly interesting.
Mozz, I've got a feeling you've mentioned this one before????
- Forums
- ASX - By Stock
- PAR
- New Player
New Player
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 29.5¢ | $8.065K | 27.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 26069 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 6625 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 26069 | 0.295 |
8 | 40042 | 0.290 |
6 | 71776 | 0.285 |
3 | 58865 | 0.280 |
3 | 16136 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 6725 | 4 |
0.305 | 64876 | 7 |
0.310 | 19787 | 2 |
0.315 | 62101 | 6 |
0.320 | 121605 | 6 |
Last trade - 10.17am 23/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |